Predictors of mortality in hospitalized children with pandemic H1N1 influenza 2009 in Pune, India
- PMID: 22012138
- PMCID: PMC7101687
- DOI: 10.1007/s12098-011-0578-7
Predictors of mortality in hospitalized children with pandemic H1N1 influenza 2009 in Pune, India
Abstract
Objective: To analyse the factors associated with increased mortality among Indian Children with H1N1.
Methods: Data were abstracted from available hospital records of children less than 12 y of age, who were admitted to Sassoon General Hospital in Pune, India, with confirmed pandemic 2009 H1N1 influenza infection from August 2009 through January 2010. Logistic regression analysis was used to identify clinical characteristics associated with mortality.
Results: Of 775 pediatric cases admitted with Influenza Like Illness (ILI), 92 (11.8%) had confirmed H1N1 influenza infection. The median age of HIN1 cases was 2.5 y; 13 (14%) had an associated co-morbid condition. Median duration of symptoms was 4 d (interquartile range (IQR), 3-7 d). All 92 H1N1 cases received oseltamivir and empiric antimicrobials on admission. Intensive care unit (ICU) admission was required for 88 (96%) children, and 20 (23%) required mechanical ventilation.Fifteen children (16%) died; mortality was associated with presence of diffuse alveolar infiltrate on admission chest radiography (odds ratio (OR) 45, 95%CI :5.4-370; p < 0.001), use of corticosteroids in ARDS in children who required mechanical ventilation (OR 8.12, 95%CI: 2.44-27.05; p = 0.001), SpO(2) <80% on admission (OR 32.8, 95% CI: 5.8-185.5; p < 0.001) and presence of ARDS (OR 345.3, 95% CI :33.5-3564.1; p < 0.001). Necropsy from all children who died showed 9 (60%) had ARDS pattern and necrotizing pneumonitis, diffuse hemorrhage and interstitial pneumonia (n = 4 each, 27%) with gram positive organisms consistent with severe viral and bacterial co-infection.
Conclusions: Hypoxia, ARDS and use of corticosteroids in children with ARDS who were mechanically ventilated were the factors associated with increased odds of mortality. Necropsy also suggested bacterial co-infection as a risk factor.
Figures


Similar articles
-
Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1): an experience from a tertiary care center in north India.Indian J Pediatr. 2010 Sep;77(9):981-5. doi: 10.1007/s12098-010-0168-0. Epub 2010 Aug 27. Indian J Pediatr. 2010. PMID: 20799074 Free PMC article.
-
Critically ill children with pandemic influenza (H1N1) in pediatric intensive care units in Turkey.Pediatr Crit Care Med. 2012 Jan;13(1):e11-7. doi: 10.1097/PCC.0b013e31820aba37. Pediatr Crit Care Med. 2012. PMID: 21263368
-
Mechanically ventilated children with 2009 pandemic influenza A/H1N1: results from the National Pediatric Intensive Care Registry in Japan.Pediatr Crit Care Med. 2012 Sep;13(5):e294-8. doi: 10.1097/PCC.0b013e31824fbb10. Pediatr Crit Care Med. 2012. PMID: 22805157
-
[Severe respiratory disease in an intensive care unit during influenza A(H1N1) 2009 pandemia].Medicina (B Aires). 2010;70(5):401-7. Medicina (B Aires). 2010. PMID: 20920955 Spanish.
-
An Eight-Year Profile of Children with Influenza A(H1N1) in a Large Hospital in India.J Trop Pediatr. 2021 Aug 27;67(4):fmab084. doi: 10.1093/tropej/fmab084. J Trop Pediatr. 2021. PMID: 34580718 Free PMC article. Review.
Cited by
-
Lessons learnt from the Indian H1N1 (swine flu) epidemic: Predictors of outcome based on epidemiological and clinical profile.J Family Med Prim Care. 2018 Nov-Dec;7(6):1506-1509. doi: 10.4103/jfmpc.jfmpc_38_18. J Family Med Prim Care. 2018. PMID: 30613550 Free PMC article.
-
Corticosteroids as adjunctive therapy in the treatment of influenza.Cochrane Database Syst Rev. 2019 Feb 24;2(2):CD010406. doi: 10.1002/14651858.CD010406.pub3. Cochrane Database Syst Rev. 2019. PMID: 30798570 Free PMC article.
-
Viral Infection in the Development and Progression of Pediatric Acute Respiratory Distress Syndrome.Front Pediatr. 2016 Nov 24;4:128. doi: 10.3389/fped.2016.00128. eCollection 2016. Front Pediatr. 2016. PMID: 27933286 Free PMC article. Review.
-
Efficacité et innocuité des corticostéroïdes dans le traitement de la COVID-19 selon des données pour la COVID-19, d’autres infections aux coronavirus, l’influenza, la pneumonie extrahospitalière et le syndrome de détresse respiratoire aiguë : revue systématique et méta-analyse.CMAJ. 2020 Nov 23;192(47):E1571-E1584. doi: 10.1503/cmaj.200645-f. CMAJ. 2020. PMID: 33229355 Free PMC article. French.
-
Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis.Sci Rep. 2020 Feb 20;10(1):3044. doi: 10.1038/s41598-020-59732-7. Sci Rep. 2020. PMID: 32080223 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical